title: Heparin bridging therapy and bleeding events in octogenarian inpatients with atrial fibrillation starting anticoagulation: results of an ancillary study.
authors.forename: Dominique
authors.initials: D
authors.lastname: Bonnet-Zamponi
authors.forename: Marie-Claude
authors.initials: MC
authors.lastname: Aumont
authors.forename: Emmanualle
authors.initials: E
authors.lastname: Comets
authors.forename: Corinne
authors.initials: C
authors.lastname: Bruhat
authors.forename: Marie-Paule
authors.initials: MP
authors.lastname: Chauveheid
authors.forename: Xavier
authors.initials: X
authors.lastname: Duval
authors.forename: Marie-Genviève
authors.initials: MG
authors.lastname: Huisse
authors.forename: Bertrand
authors.initials: B
authors.lastname: Diquet
authors.forename: Gilles
authors.initials: G
authors.lastname: Berrut
authors.forename: France
authors.initials: F
authors.lastname: Mentre
authors.forename: Sandrine
authors.initials: S
authors.lastname: Delpierre
authors.forename: Sylvie
authors.initials: S
authors.lastname: Legrain
mesh_terms: D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D015994:Incidence; D007297:Inpatients; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D000925:Anticoagulants; D006493:Heparin